Join the 200th Anniversary Celebration

Images in Clinical Medicine

Crystalluria from Acyclovir Use

William J. Mason, M.D., and Hilary H. Nickols, M.D., Ph.D.

N Engl J Med 2008; 358:e14March 27, 2008

Article

A 60-year-old man infected with the human immunodeficiency virus (HIV) (CD4 count of 450 per cubic millimeter and HIV viral load of <50 copies per milliliter) who had HIV-associated dementia was admitted to our hospital because of an altered mental status, a temperature of 101°F (38.3°C), and seizure-like activity. His medications included efavirenz, emtricitabine, tenofovir, and pravastatin sodium. Empirical treatment with intravenous acyclovir (10 mg per kilogram of body weight) and antibiotics was initiated before the patient underwent a lumbar puncture. Two hours after the administration of acyclovir, his urine became cloudy and white in the proximal portion of the Foley catheter, with clear yellow urine distally. A urinalysis was remarkable for a specific gravity of 1.025 with a urinary pH of 5.0. Ketones, albumin, and blood were detected. Microscopical analysis revealed birefringent needle-shaped crystals (Panel A; visualized under polarizing light in Panel B), a finding consistent with the precipitation of acyclovir. His serum creatinine level increased from 0.7 to 1.1 mg per deciliter (62 to 97 μmol per liter) and returned to the baseline level after the discontinuation of acyclovir and administration of 2 liters of normal saline. Additional treatment with intravenous acyclovir did not result in urinary crystallization of the drug. A lumbar puncture was unremarkable, and an infectious pathogen was not detected. It was concluded that the signs and symptoms on presentation were due to HIV-associated dementia and that the seizure-like activity was myoclonus. The patient was discharged to hospice care.

William J. Mason, M.D.
Hilary H. Nickols, M.D., Ph.D.
Vanderbilt University Medical Center, Nashville, TN 37232

Citing Articles (4)

Citing Articles

  1. 1

    Patrina Gunness, Katarina Aleksa, John Bend, Gideon Koren. (2011) Acyclovir-induced nephrotoxicity: the role of the acyclovir aldehyde metabolite. Translational Research 158:5, 290-301
    CrossRef

  2. 2

    Patrina Gunness, Katarina Aleksa, Gideon Koren. (2011) Acyclovir is a substrate for the human breast cancer resistance protein (BCRP/ABCG2): implications for renal tubular transport and acyclovir-induced nephrotoxicity. Canadian Journal of Physiology and Pharmacology 89:9, 675-680
    CrossRef

  3. 3

    Patrina Gunness, Katarina Aleksa, Kazuhiro Kosuge, Shinya Ito, Gideon Koren. (2010) Comparison of the novel HK-2 human renal proximal tubular cell line with the standard LLC-PK1 cell line in studying drug-induced nephrotoxicity. Canadian Journal of Physiology and Pharmacology 88:4, 448-455
    CrossRef

  4. 4

    (2008) Current awareness: Pharmacoepidemiology and drug safety. Pharmacoepidemiology and Drug Safety 17:9, i-xvi
    CrossRef